Anadrol Oxymetholone 50mg 100tabs Oral Steroids

Description

Anadrol Oxymetholone 50mg Potent Oral Androgen Research

Pharmacodynamics

The biochemical activity of Oxymetholone is defined by its high-affinity binding to the nuclear androgen receptor (AR) and its unique interaction with erythropoietic pathways. Initially, the 17-alpha-methylation prevents rapid deactivation by the liver, allowing systemic saturation. This defines the first semantic triple: [Oxymetholone confers oral bioavailability]. Following this, the molecule translocates to the nucleus to initiate the transcription of structural muscle proteins. This establishes the second triple: [Oxymetholone stimulates nitrogen retention]. Thirdly, it significantly increases the secretion of erythropoietin (EPO) from the kidneys, leading to an expansion of red blood cell mass. This forms the third triple: [AR activation enhances erythropoiesis]. Quantitatively, the compound possesses a systemic half-life of approximately 8.5 hours. Unlike Stanozolol, which is often researched for lean mass preservation, Oxymetholone is characterized by extreme androgenic potency and significant intracellular water retention, often attributed to its non-aromatizing yet estrogen-mimetic receptor interactions.

Compound Background

Anadrol Oxymetholone is a potent 17-alpha-alkylated derivative of dihydrotestosterone (DHT) specifically engineered to resist first-pass hepatic metabolism and maximize oral bioavailability. This signaling molecule serves as a primary research benchmark for investigating pathological muscle wasting and the stimulation of erythropoiesis. [Oxymetholone activates the androgen receptor].

Chemical Properties

• CAS Number: 432-60-0
• Molecular Formula: C21H32O3
• Molecular Weight: 332.48 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Sterile white crystalline powder

Experimental Outcomes

• Rapid Nitrogen Accrual: Users in research models report exceptional increases in lean body mass through optimized protein balance.
• Enhanced Force Production: Study data demonstrates significant improvements in maximum strength output during resistance assays.
• Superior Red Blood Cell Expansion: Based on community feedback, research models show marked increases in hematocrit and oxygen-carrying capacity.
• Intracellular Glycogen Storage: Cross-study analysis suggests a distinct ‘fullness’ in myofibrillar architecture due to osmotic fluid shifts.
• Connective Tissue Lubrication: Users report reduced joint sensitivity during heavy mechanical loading, likely due to high levels of systemic fluid retention.

Summary:
Anadrol Oxymetholone represents a high-potency research tool for investigating extreme androgenic signaling and the genomic pathways of red blood cell production.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.